Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.
Cytokine Growth Factor Rev., 21(2-3):169-75 (2010)
Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes.
Clin Adv Hematol Oncol., Jan;8(1):40-6 (2010)
The stilbenoid tyrosine kinase inhibitor, G6, suppresses Jak2-V617F-mediated human pathological cell growth in vitro and in vivo.
J. Biol. Chem., Feb;286(6):4280-91 (2011)
Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries.
Blood., Jun;117(26):7121-5 (2011)
Angiogenesis in acute myeloid leukemia and opportunities for novel therapies.
J Oncol., 2012:128608 (2012)
The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow.
Neoplasia., Nov;13(11):1058-68 (2011)
Oncolytic virotherapy for hematological malignancies.
Adv Virol., 2012:186512 (2012)
An overview of stem cell research and regulatory issues.
Mayo Clin. Proc., Aug;78(8):993-1003 (2003)
Adult human hematopoietic cells provide functional hemangioblast activity.
Blood., Jan;103(1):133-5 (2004)
Bone marrow transdifferentiation in brain after transplantation: a retrospective study.
Lancet., May;363(9419):1432-7 (2004)
Developmental differences in megakaryocyte maturation are determined by the microenvironment.
Stem Cells., Oct;23(9):1400-8 (2005)
Typhlitis with concurrent appendicitis in a patient with chronic lymphocytic leukemia.
Clin Adv Hematol Oncol., May;1(5):284-6; discussion 286 (2003)
Stem cell research.
Paediatr Respir Rev., Jun;7(2):135-40 (2006)
Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry.
Stem Cells., Aug;25(8):1881-7 (2007)
The hunt for cancer-initiating cells: a history stemming from leukemia.
Leukemia., Aug;21(8):1619-27 (2007)
Marrow cell therapies for cardiovascular diseases.
Exp. Hematol., Jun;36(6):687-94 (2008)
Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma.
Am. J. Hematol., Jul;73(3):169-75 (2003)
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro.
Leuk. Res., May;36(5):619-24 (2012)
Aldehyde dehydrogenase activity as a functional marker for lung cancer.
Chem. Biol. Interact., Mar;178(1-3):48-55 (2009)
Diagnostic testing, treatment, cost of care, and survival among registered and non-registered patients with myelodysplastic syndromes.
Leuk. Res., Nov;35(11):1453-6 (2011)
Underreporting of myeloid malignancies by United States cancer registries.
Cancer Epidemiol. Biomarkers Prev., Mar;21(3):474-81 (2012)
The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells.
J Transl Med., 4:9 (2006)
Mapping hematopoiesis in a fully regenerative vertebrate: the axolotl.
Fishing for myelodysplastic syndromes finds uncaptured cases by state cancer registries: Need for more resources.
Functional integration of acute myeloid leukemia into the vascular niche.
Radiation alone for solid tumors and the questionable development of therapy-related myelodysplastic syndromes.
Journal of the National Cancer Institute, 106, dju025 (2014)